Infantile Galactosialidosis with Novel Mutation: An Early Presentation

Abstract

Galactosialidosis (GS) is a rare lysosomal storage disorder. We reported here, the case of a 29-day-old boy who had increased body swelling, difficulty breathing, and petechiae on the trunk since birth. The antenatal history was unremarkable. Clinical laboratory findings included coarse facies, hepatosplenomegaly, gross ascites, thrombocytopenia, nephrotic range proteinuria, and bilateral hydronephrosis. The diagnostic challenge was resolved after genetic testing, which revealed GS with a novel homozygous c.1158dupA mutation.

Keywords

galactosialidosis - anasarca - thrombocytopenia - neonatal ascites - congenital nephrotic syndrome

Publication History

Received: 12 February 2021

Accepted: 22 May 2021

Article published online:
29 July 2021

• References

• 1 Palmeri S, Hoogeveen AT, Verheijen FW, Galjaard H. Galactosialidosis: molecular heterogeneity among distinct clinical phenotypes. Am J Hum Genet 1986; 38 (02) 137-148
• 2 De Pasquale V, Moles A, Pavone LM. Cathepsins in the pathophysiology of mucopolysaccharidoses: new perspectives for therapy. Cells 2020; 9 (04) 979
• 3 Nanba E, Tsuji A, Omura K, Suzuki Y. Galactosialidosis: a direct evidence that a 46-kilodalton protein restores deficient enzyme activities in fibroblasts. Biochem Biophys Res Commun 1987; 144 (01) 138-142
• 4 Takano T, Shimmoto M, Fukuhara Y. et al. Galactosialidosis: clinical and molecular analysis of 19 Japanese patients. Brain Dysfunct 1991; 4: 271-280
• 5 Zhou X-Y, van der Spoel A, Rottier R. et al. Molecular and biochemical analysis of protective protein/cathepsin A mutations: correlation with clinical severity in galactosialidosis. Hum Mol Genet 1996; 5 (12) 1977-1987
• 6 Matsumoto N, Gondo K, Kukita J, Higaki K, Paragison RC, Nanba E. A case of galactosialidosis with a homozygous Q49R point mutation. Brain Dev 2008; 30 (09) 595-598
• 7 Caciotti A, Catarzi S, Tonin R. et al. Galactosialidosis: review and analysis of CTSA gene mutations. Orphanet J Rare Dis 2013; 8: 114
• 8 Shamseldin HE, Tulbah M, Kurdi W. et al. Identification of embryonic lethal genes in humans by autozygosity mapping and exome sequencing in consanguineous families. Genome Biol 2015; 16: 116
• 9 Riggs CB, Escobar LF, Tucker ME. Early-infantile galactosialidosis: clinical and radiological findings. J Clin Med Case Rep 2015; 2 (02) 4
• 10 Kostadinov S, Shah BA, Alroy J, Phornphutkul C. A case of galactosialidosis with novel mutations of the protective protein/cathepsin a gene: diagnosis prompted by trophoblast vacuolization on placental examination. Pediatr Dev Pathol 2014; 17 (06) 474-477
• 11 Kartal A, Aydın K. A Turkish case of galactosialidosis with a new homozygous mutation in CTSA gene. Metab Brain Dis 2017; 32 (04) 973-975
• 12 Okulu E, Tunc G, Eminoglu T, Erdeve O, Atasay B, Arsan S. Galactosialidosis in a newborn with a novel mutation in the CTSA gene presenting with transient hyperparathyroidism. Balkan J Med Genet 2017; 20 (02) 95-98
• 13 Aldámiz-Echevarría L, Couce ML, Villate O, Fernández-Marmiesse A, Piñán MÁ. New CTSA mutation in early infantile galactosialidosis. Pediatr Int 2018; 60: 761-762
• 14 Kleijer WJ, Geilen GC, Janse HC. et al. Cathepsin A deficiency in galactosialidosis: studies of patients and carriers in 16 families. Pediatr Res 1996; 39 (06) 1067-1071
• 15 Hossain MA, Higaki K, Shinpo M. et al. Chemical chaperone treatment for galactosialidosis: Effect of NOEV on β-galactosidase activities in fibroblasts. Brain Dev 2016; 38 (02) 175-180
• 16 Shimmoto M, Fukuhara Y, Itoh K, Oshima A, Sakuraba H, Suzuki Y. Protective protein gene mutations in galactosialidosis. J Clin Invest 1993; 91 (06) 2393-2398
• 17 Galjart NJ, Gillemans N, Harris A. et al. Expression of cDNA encoding the human “protective protein” associated with lysosomal beta-galactosidase and neuraminidase: homology to yeast proteases. Cell 1988; 54 (06) 755-764
• 18 Groener J, Maaswinkel-Mooy P, Smit V. et al. New mutations in two Dutch patients with early infantile galactosialidosis. Mol Genet Metab 2003; 78 (03) 222-228